SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
Show
20
per page| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| PerkinElmer U.S. LLC | Pharmaceuticals, Biotechnology and Life Sciences | Northern America | Targets set | Large | 1 | Jun 12, 2025 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year 2034 Long-Term Status - Net-Zero Status - Net-Zero Year - Sector Pharmaceuticals, Biotechnology and Life Sciences Region Northern America Organization Type Corporate Location United States of America Company Size Large Target Statement Near-Term Targets: PerkinElmer commits to reduce absolute scope 1 GHG emissions 58.8% by 2034 from a 2023 base year. PerkinElmer also commits to increase active annual sourcing of renewable electricity from 0% in 2023 to 100% by 2030. PerkinElmer further commits to reduce scope 3… Stakeholders EVP, Corporate Communications, Sustainability, Brand | |||||||
Show
20
per pageTurn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.